IndraLab

Statements


TYSND1 affects JOSD2
3 |
3 |

No evidence text available

No evidence text available

No evidence text available
TRAPPC2 affects JOSD2
3 |
3 |

No evidence text available

No evidence text available

No evidence text available
JOSD2 affects TYSND1
3 |
3 |

No evidence text available

No evidence text available

No evidence text available
JOSD2 affects TRAPPC2
3 |
3 |

No evidence text available

No evidence text available

No evidence text available
JOSD2 affects AHCYL2
3 |
3 |

No evidence text available

No evidence text available

No evidence text available
JOSD2 affects AHCYL1
3 |
3 |

No evidence text available

No evidence text available

No evidence text available
AHCYL2 affects JOSD2
3 |
3 |

No evidence text available

No evidence text available

No evidence text available
AHCYL1 affects JOSD2
3 |
3 |

No evidence text available

No evidence text available

No evidence text available
2 |
Valproic acid methylates JOSD2.
1 |
1 |

No evidence text available
Valproic acid increases the amount of JOSD2.
1 |
Valproic acid increases the amount of JOSD2. 1 / 1
1 |

No evidence text available
UBC affects JOSD2
2 |
2 |

No evidence text available

No evidence text available
SPRR3 affects JOSD2
2 |
2 |

No evidence text available

No evidence text available
PITX2 affects JOSD2
2 |
PITX2 decreases the amount of JOSD2. 2 / 2
2 |

No evidence text available

No evidence text available
Niclosamide affects JOSD2
2 |
Niclosamide increases the amount of JOSD2. 2 / 2
2 |

No evidence text available

No evidence text available
MCEMP1 affects JOSD2
2 |
2 |

No evidence text available

No evidence text available
| 1 1
| 1

reach
"JOSD2 deficiency displays cytostatic effects and reduces glycolysis in a broad spectrum of tumor cells of distinct origin and its expression correlates with poor prognosis in non small cell lung cancer."
| 1

eidos
"JOSD2 deficiency displays cytostatic effects and reduces glycolysis in a broad spectrum of tumor cells of distinct origin and its expression correlates with poor prognosis in non-small cell lung cancer ."
JOSD2 affects UBC
2 |
2 |

No evidence text available

No evidence text available
JOSD2 affects SPRR3
2 |
2 |

No evidence text available

No evidence text available
JOSD2 affects MCEMP1
2 |
2 |

No evidence text available

No evidence text available
JOSD2 affects HBB
2 |
2 |

No evidence text available

No evidence text available
JOSD2 affects DUSP28
2 |
2 |

No evidence text available

No evidence text available
HBB affects JOSD2
2 |
2 |

No evidence text available

No evidence text available
ELK1 affects JOSD2
2 |
ELK1 decreases the amount of JOSD2. 2 / 2
2 |

No evidence text available

No evidence text available
DUSP28 affects JOSD2
2 |
2 |

No evidence text available

No evidence text available
6-propyl-2-thiouracil decreases the amount of JOSD2. 2 / 2
2 |

No evidence text available

No evidence text available
2,3,7,8-tetrachlorodibenzodioxine increases the amount of JOSD2.
1 |
1 |

No evidence text available
2,3,7,8-tetrachlorodibenzodioxine decreases the amount of JOSD2.
1 |
1 |

No evidence text available
17alpha-ethynylestradiol increases the amount of JOSD2.
1 |
17alpha-ethynylestradiol increases the amount of JOSD2. 1 / 1
1 |

No evidence text available
17alpha-ethynylestradiol decreases the amount of JOSD2.
1 |
17alpha-ethynylestradiol decreases the amount of JOSD2. 1 / 1
1 |

No evidence text available
Zinc atom affects JOSD2
1 |
Zinc atom increases the amount of JOSD2. 1 / 1
1 |

No evidence text available
Topotecan affects JOSD2
1 |
Topotecan decreases the amount of JOSD2. 1 / 1
1 |

No evidence text available
Tetrachloromethane increases the amount of JOSD2. 1 / 1
1 |

No evidence text available
1 |
Sodium arsenite increases the amount of JOSD2. 1 / 1
1 |

No evidence text available
Oxaliplatin affects JOSD2
1 |
Oxaliplatin decreases the amount of JOSD2. 1 / 1
1 |

No evidence text available
Nefazodone affects JOSD2
1 |
Nefazodone increases the amount of JOSD2. 1 / 1
1 |

No evidence text available
Methyl methanesulfonate increases the amount of JOSD2. 1 / 1
1 |

No evidence text available
Glafenine affects JOSD2
1 |
Glafenine increases the amount of JOSD2. 1 / 1
1 |

No evidence text available
Flutamide affects JOSD2
1 |
Flutamide increases the amount of JOSD2. 1 / 1
1 |

No evidence text available
Decabromodiphenyl ether decreases the amount of JOSD2. 1 / 1
1 |

No evidence text available
1 |
Cyclosporin A increases the amount of JOSD2. 1 / 1
1 |

No evidence text available
Coumarin affects JOSD2
1 |
Coumarin increases the amount of JOSD2. 1 / 1
1 |

No evidence text available
1 |
Cobalt dichloride decreases the amount of JOSD2. 1 / 1
1 |

No evidence text available
Cadmium dichloride increases the amount of JOSD2. 1 / 1
1 |

No evidence text available
Atrazine affects JOSD2
1 |
Atrazine increases the amount of JOSD2. 1 / 1
1 |

No evidence text available
1 |
Aluminium atom decreases the amount of JOSD2. 1 / 1
1 |

No evidence text available
1 |
1 |

No evidence text available
Acetamide affects JOSD2
1 |
Acetamide increases the amount of JOSD2. 1 / 1
1 |

No evidence text available
Ubiquitin affects JOSD2
| 1

sparser
"Additionally, in the covalent complex of JOSD2 and ubiquitin, the ubiquitin molecule is covalently attached to cysteine-24, which moves side chain of this residue away from histine-125 and toward the binding site of the substrate."
TFAP2C affects JOSD2
1 |
TFAP2C decreases the amount of JOSD2. 1 / 1
1 |

No evidence text available
TFAP2A affects JOSD2
1 |
TFAP2A decreases the amount of JOSD2. 1 / 1
1 |

No evidence text available
STUB1 affects JOSD2
1 |
1 |

No evidence text available
SP3 affects JOSD2
1 |
SP3 decreases the amount of JOSD2. 1 / 1
1 |

No evidence text available
SMARCA2 affects JOSD2
1 |
1 |

No evidence text available

No evidence text available
RFX1 affects JOSD2
1 |
RFX1 decreases the amount of JOSD2. 1 / 1
1 |

No evidence text available
PLA2G2A affects JOSD2
1 |
1 |

No evidence text available
PAX4 affects JOSD2
1 |
PAX4 decreases the amount of JOSD2. 1 / 1
1 |

No evidence text available
PAX3 affects JOSD2
1 |
PAX3 decreases the amount of JOSD2. 1 / 1
1 |

No evidence text available
NLRP3 affects JOSD2
| 1
JOSD2 binds NLRP3. 1 / 1
| 1

isi
"This was mediated by enhanced deubiquitination of NLRP3 via binding with deubiquitinases BRCC3 and JOSD2, which are highly expressed in myeloid cells."
NDUFA8 affects JOSD2
1 |
1 |

No evidence text available
MEF2A affects JOSD2
1 |
MEF2A decreases the amount of JOSD2. 1 / 1
1 |

No evidence text available
LRTOMT affects JOSD2
1 |
1 |

No evidence text available
JOSD2 affects cell death
| 1
| 1

reach
"Furthermore, in contrast to the control siRNA treated cells, siRNA depletion of JOSD2 caused selective cell death in high-PHGDH-expressing cells, but not in low expressing cell lines."
JOSD2 affects Ubiquitin
| 1

sparser
"Additionally, in the covalent complex of JOSD2 and ubiquitin, the ubiquitin molecule is covalently attached to cysteine-24, which moves side chain of this residue away from histine-125 and toward the binding site of the substrate."
JOSD2 affects STUB1
1 |
1 |

No evidence text available
JOSD2 affects SMARCA2
1 |
1 |

No evidence text available
JOSD2 affects PLA2G2A
1 |
1 |

No evidence text available
JOSD2 affects NLRP3
| 1
JOSD2 binds NLRP3. 1 / 1
| 1

isi
"This was mediated by enhanced deubiquitination of NLRP3 via binding with deubiquitinases BRCC3 and JOSD2, which are highly expressed in myeloid cells."
JOSD2 affects NDUFA8
1 |
1 |

No evidence text available
JOSD2 affects LRTOMT
1 |
1 |

No evidence text available
JOSD2 affects COMMD3
1 |
1 |

No evidence text available
JOSD2 affects BRCC3
| 1
BRCC3 binds JOSD2. 1 / 1
| 1

isi
"This was mediated by enhanced deubiquitination of NLRP3 via binding with deubiquitinases BRCC3 and JOSD2, which are highly expressed in myeloid cells."
ICG 001 affects JOSD2
1 |
ICG 001 decreases the amount of JOSD2. 1 / 1
1 |

No evidence text available
GCM1 affects JOSD2
1 |
GCM1 decreases the amount of JOSD2. 1 / 1
1 |

No evidence text available
GATA1 affects JOSD2
1 |
GATA1 decreases the amount of JOSD2. 1 / 1
1 |

No evidence text available
COMMD3 affects JOSD2
1 |
1 |

No evidence text available
1 |
C646 compound decreases the amount of JOSD2. 1 / 1
1 |

No evidence text available
BRCC3 affects JOSD2
| 1
BRCC3 binds JOSD2. 1 / 1
| 1

isi
"This was mediated by enhanced deubiquitination of NLRP3 via binding with deubiquitinases BRCC3 and JOSD2, which are highly expressed in myeloid cells."
AR affects JOSD2
1 |
AR decreases the amount of JOSD2. 1 / 1
1 |

No evidence text available
1 |
(+)-JQ1 compound decreases the amount of JOSD2. 1 / 1
1 |

No evidence text available
1 |

No evidence text available